RXi Selects Candidate in Anti-Scarring Program as Promised, But Will Likely Miss Partnership Goal

Although the selection of the drug candidate marks the achievement of one of RXi's key goals for 2010, its other — the establishment of an industry partnership — isn't likely to be meet, based on a statement from a company official.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories